Semaglutide demonstrates efficacy in improving liver fibrosis across diverse subpopulations in part 1 of the ESSENCE trial outcomes in Asian and non-Asian populations
Authors:
Jacob George 1; Atsushi Nakajima 2; Chun-Jen Liu 3; Won Kim 4; George Boon Bee Goh 5; Jidong Jia 6; Kwabena Opuni 7; Niels Krarup 7; Mette Skalshøi Kjær 7; Anna Maria Bartyzel 7 & Arun J. Sanyal 8.